VPRIV Rx

Select the drug indication to add to your list

VPRIV

Inborn errors of metabolism
Only 4 drugs may be compared at once

Generic Name and Formulations:

Velaglucerase alfa 400 Units/vial; lyophilized pwd for IV infusion after reconstitution; preservative-free.

Company:

Shire US, Inc.

Select therapeutic use:

Indications for VPRIV:

Long-term enzyme replacement therapy (ERT) in patients with Type 1 Gaucher disease.

Adults and Children:

<4yrs: not established. Give by IV infusion over 60 minutes. Individualize. ≥4yrs: 60 Units/kg every other week; adjust dose based on therapeutic goals. Begin treatment with Vpriv at the same dose when switching from imiglucerase.

Warnings/Precautions:

Monitor for hypersensitivity reactions; immediately discontinue and treat appropriately if occur. Temporarily discontinue and resume with increased infusion time, slowing infusion rate, or administer antihistamines, antipyretics, and/or corticosteroids if infusion-related reactions occur. Elderly. Pregnancy (Cat.B). Nursing mothers.

Pharmacological Class:

Lysosomal glucocerebroside-specific enzyme.

Adverse Reactions:

Infusion-related reactions, headache, dizziness, abdominal pain, nausea, back pain, joint pain, upper respiratory tract infection, activated PTT prolonged, fatigue/asthenia, pyrexia.

Generic Availability:

NO

How Supplied:

Single-use vials—1

VPRIV 400 units vials (Qty:1)

appx. price $1401.00